Keywords: ec, clears, short-course, pegasys/copegus, swiss, drug, major

EC clears short-course Pegasys/Copegus

Article | 12 March 2007

Print This

Swiss drug major Roche says that the European Commission has approved a new short-course therapy for hepatitis C patients that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in